Florian Viehweger

Hamburg, HH 20246, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease.

TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease.

Journal: Cancers

Published: May 31, 2026

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Journal: Biomedicines

Published: February 17, 2026

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

Journal: Diagnostics (Basel, Switzerland)

Published: February 16, 2026

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Journal: Frontiers in oncology

Published: February 12, 2026

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Journal: Molecular medicine (Cambridge, Mass.)

Published: December 16, 2025

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Journal: Virchows Archiv : an international journal of pathology

Published: November 04, 2025

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Journal: Experimental and molecular pathology

Published: July 23, 2025

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Journal: Cancer medicine

Published: July 22, 2025

Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors.

Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors.

Journal: Biomedicines

Published: April 23, 2025

MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder.

MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder.

Journal: Scientific reports

Published: February 14, 2025

Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas.

Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas.

Journal: Cancers

Published: February 03, 2025

Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.

Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.

Journal: PloS one

Published: December 11, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026